The group's principle activity is to develop therapies for the treatment of auto immune disease. The group provides treatments for autoimmune diseases include Multiple Sclerosis, Rheumatoid Arthritis, Celiac Disease, Uveitis, Systemic Lupus Erythematosus, Crohn’s disease, Grave’s Disease and type 1 Diabetes. The group operates from United States.
